Search

Search Constraints

You searched for: Author/Creator Niu, Jiaxin

Search Results

1. 304 Intratumoral injection of CMP-001, a toll-like receptor 9 (TLR9) agonist, in combination with pembrolizumab reversed programmed death receptor 1 (PD-1) blockade resistance in advanced melanoma. (9th November 2020)

2. 396 Overcoming resistance to anti-PD-1 with tumor agnostic NBTXR3: from bench to bed side. (9th November 2020)

3. 396 Overcoming resistance to anti-PD-1 with tumor agnostic NBTXR3: from bench to bed side. (9th November 2020)

6. 422 An open-label, multicenter, phase 1/2 clinical trial of RP1, an enhanced potency oncolytic HSV, combined with nivolumab: updated results from the skin cancer cohorts. (9th November 2020)

7. Anti–cytotoxic T-lymphocyte–associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer. (September 2021)